You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
個股熱度排行 | 1月9日美股盤前

根據uSMART輿情監測數據,週末期間,中國投資者關注指數最高的5只股票是阿裏巴巴、特斯拉、蘋果、輝瑞、京東。

1月9日—美股關注排行TOP5

輿情變化榜單

阿裏巴巴

個股K線圖

關注度第一爲阿裏巴巴,該股上個交易日收盤上漲2.70%,報於107.40美元。近5個交易日累計上漲20.50%。在消息面和社交媒體方面,輿情以看多爲主。較被市場關注的消息有:

2022年更名和換LOGO的40個大公司和品牌:阿裏巴巴、比亞迪、百威英博、賽諾菲都換標了

阿裏巴巴盤前漲超5%,大摩3年來首次將其列爲科網首選,目標價上調50%

特斯拉

個股K線圖

關注度第二爲特斯拉,該股上個交易日收盤上漲2.47%,報於113.06美元。近5個交易日累計下跌7.19%。在消息面和社交媒體方面,輿情以看多爲主。較被市場關注的消息有:

比亞迪銷售新能源車逾186萬輛超特斯拉 加速海外佈局年售5.59萬輛猛增307%

數據顯示:特斯拉Model Y進入2022年美國十大最暢銷汽車榜單

蘋果

個股K線圖

關注度第三爲蘋果,該股上個交易日收盤上漲3.68%,報於129.62美元。近5個交易日累計上漲0.01%。在消息面和社交媒體方面,輿情以看多爲主。較被市場關注的消息有:

天風郭明⭏9:蘋果取消iPhone SE 4生產計劃 高通成最大贏家

蘋果加速轉移生產線 印度出口iPhone總額按年升近1倍

輝瑞

個股K線圖

關注度第四爲輝瑞,該股上個交易日收盤上漲2.54%,報於50.92美元。近5個交易日累計下跌0.80%。在消息面和社交媒體方面,輿情以看多爲主。較被市場關注的消息有:

這國首都地鐵相撞,致1死57傷!俄軍發動"報復行動"!兩大新冠藥納入醫保,輝瑞"出局"

醫保藥品目錄談判結束,2種新冠藥被納入,輝瑞新冠藥價高未能入選!節後資金“搶跑”入場

京東

個股K線圖

關注度第五爲京東,該股上個交易日收盤下跌2.43%,報於64.30美元。近5個交易日累計上漲12.63%。在消息面和社交媒體方面,輿情以看多爲主。較被市場關注的消息有:

中信證券維持京東“買入”評級 料第四季營收2950億人民幣

國盛證券:重申京東集團-SW“買入”評級 目標價320港元

此外,監測期內有1只股票的輿情出現大扭轉,意味着在消息面上出現了可能影響公司股價趨勢的事件或者轉折。

1月9日—美股輿情轉折預警

輿情變化榜單

阿裏巴巴

個股K線圖

阿裏巴巴輿情扭轉指數達99,目前輿情方向爲利好,表明公司出現了被投資者視作較大利好的消息。

其中較被市場關注的消息有:

2022年更名和換LOGO的40個大公司和品牌:阿裏巴巴、比亞迪、百威英博、賽諾菲都換標了

阿裏巴巴盤前漲超5%,大摩3年來首次將其列爲科網首選,目標價上調50%

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account